TABLE 1.
Total | Positive CT | Positive GC | Positive CT/GC | Univariate OR (95% CI) | P | Multivariate AOR, 95% CI* | |
---|---|---|---|---|---|---|---|
Total | 1037 | 37 (3.6) | 46 (4.6) | 74 (7.1) | — | — | — |
Age | |||||||
Mean, SD | 34.9 (7.9) | 29.1 (6.9) | 29.2 (7.2) | 29.7 (7.3) | — | — | — |
<25 | 79 (7.6) | 5 (6.3) | 8 (10.2) | 13 (16.5) | 5.55 (2.56–12.5) | <0.001 | 5.00 (2.33–11.11) |
25–35 | 475 (45.8) | 23 (4.8) | 27 (5.9) | 42 (8.8) | 2.27 (1.15–4.55) | 2.04 (1.02–4.17) | |
>35 | 483 (46.6) | 9 (1.9) | 11 (2.4) | 19 (3.9) | Reference | — | Reference |
Race | |||||||
Black | 875 (85.4) | 34 (3.9) | 38 (4.5) | 63 (7.2) | Reference | 0.13 | — |
White | 133 (13.0) | 2 (1.5) | 7 (5.3) | 9 (6.8) | 0.79 (0.35–1.78) | — | — |
Other | 16 (1.6) | 1 (6.3) | 1 (6.7) | 2 (12.5) | 2.41 (0.52–11.13) | — | — |
CD4 count | |||||||
<200 | 319 (32.0) | 13 (4.1) | 10 (3.4) | 19 (6.0) | Reference | 0.31 | — |
200–400 | 302 (30.3) | 8 (2.6) | 13 (4.4) | 18 (6.0) | 1.06 (0.54–2.08) | — | — |
>400 | 376 (37.7) | 15 (4.0) | 19 (5.3) | 32 (8.5) | 1.57 (0.86–2.86) | — | — |
HIV viral load | |||||||
<400 | 303 (30.8) | 6 (2.0) | 11 (3.7) | 16 (5.3) | Reference | 0.03 | Reference |
400–10,000 | 254 (25.8) | 15 (5.9) | 16 (6.5) | 27 (10.6) | 2.06 (1.11–3.92) | — | 1.70 (0.87–3.31) |
>10,000 | 426 (43.3) | 14 (3.3) | 15 (5.0) | 26 (6.1) | 1.17 (0.63–2.22) | — | 1.01 (0.52–1.93) |
HAART | |||||||
No | 785 (75.7) | 31 (3.9) | 40 (5.3) | 63 (8.0) | Reference | 0.05 | Reference |
Yes | 252 (24.3) | 6 (2.4) | 6 (2.5) | 11 (4.4) | 0.52 (0.27–1.01) | — | 0.60 (0.31–1.19) |
HIV risk IVDU | |||||||
No | 598 (57.7) | 26 (4.3) | 25 (5.3) | 45 (7.5) | Reference | 0.57 | — |
Yes | 439 (42.3) | 11 (2.5) | 21 (5.1) | 29 (6.6) | 0.87 (0.54–1.41) | — | — |
Heterosexual: HIV3 partner | |||||||
No | 644 (62.1) | 24 (3.7) | 26 (4.2) | 45 (7.0) | Reference | 0.81 | — |
Yes | 393 (37.9) | 13 (3.3) | 20 (5.2) | 29 (7.4) | 1.06 (0.65–1.72) | — | — |
High risk partner | |||||||
No | 566 (54.5) | 18 (3.2) | 25 (4.6) | 39 (6.9) | Reference | 0.74 | — |
Yes | 471 (45.5) | 19 (4.0) | 21 (4.6) | 35 (7.4) | 1.08 (0.68–1.74) | — | — |
Values expressed as number (percentage) unless otherwise noted. One thousand thirty-seven women were tested for CT and 996 for GC.
Race was missing for 13 individuals, CD4 count was missing for 40 individuals, and HIV viral load was missing for 54 individuals.
Multivariate regression model includes age, viral load, and HAART. OR and AOR are for CT and GC as combined outcomes.
AOR indicates adjusted odds ratio; IVDU, intravenous drug use.